GATA6 is a transcriptional activator and pioneer factor that regulates multiple developmental and pathological processes 12. During early human cardiogenesis, GATA6 regulates WNT and BMP signaling programs essential for cardiac progenitor cell specification and mesoderm patterning; GATA6 haploinsufficiency causes congenital heart disease with variable pancreatic or diaphragm defects 3. In pancreatic cancer, GATA6 expression distinguishes classical from chemoresistant basal-like subtypes of pancreatic ductal adenocarcinoma and serves as a prognostic biomarker 4. GATA6 functions as a pioneer factor in colorectal cancer, binding preferentially at CRC-specific enhancers and regulating 3D genome organization through CTCF interaction; GATA6 knockout impairs cancer cell proliferation and tumor growth 5. In vascular pathology, GATA6 is aberrantly upregulated during arterial calcification and promotes vascular smooth muscle cell senescence by counteracting the anti-aging factor SIRT6 and impairing DNA damage repair 6. Additionally, GATA6 loss cooperates with Wnt-deficient and hypoxic environments to drive squamous cell reprogramming in pancreatic cancer 7. These findings establish GATA6 as a key regulator of cell identity, lineage specification, and disease pathogenesis across multiple tissues and cancer types.